Clinical Trial Update: A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) [Phase 2]

View source ↗

Summary

Phase 2 study of RIST4721 in palmoplantar pustulosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis

Drugs mentioned

• RIST4721

Snippet

Sponsor: Aristea Therapeutics, Inc. | Conditions: Palmoplantar Pustulosis | Phase 2 | Status: COMPLETED | Results posted: 2022-03-03